新闻动态
News
-
1月3日晚8点，「铜娃娃夜话」——聊聊肝豆状核变性基因治疗那些事儿
同病相连，不“铜”人生！
2025-01-03
-
Lingyi Bio Wins '2024 China Biopharma Industry Chain Innovation Storm List' Annual Industry Attention Award for Rare Disease Drugs
2025-01-03
-
Lingyi Bio Honored as One of the 'Top 10 Innovative Companies in Precision Medicine for 2024'
2025-01-03
-
Joining Forces for Mutual Success: Lingyi Biotech and Jolly Pharmaceutical Enter Strategic Partnership Framework Agreement
2025-01-03
-
Lingyi Bio's Self-Developed Gene Therapy Drug LY-M001 Injection Receives FDA Rare Pediatric Disease Designation
2025-01-03
-
Breakthrough in Pediatric Care: Shanghai Children's Medical Center Achieves First-Ever Gene Therapy for Type I Gaucher Disease in Adolescents
2025-01-03
-
Lingyi Bio Achieves Milestone with First Dose of LY-M003 Injection in Gene Therapy Clinical Trial for Wilson's Disease
2025-01-03
-
Lingyi Bio Initiates Clinical Trial of LY-M003 Injection for the Treatment of Wilson's Disease in Adults
2025-01-03
